tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Financial Statements

Compare
74 Followers

Immucell Financial Overview

Immucell's market cap is currently $47.05M. The company's EPS TTM is $-0.28; its P/E ratio is ―; Immucell is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 17.47M$ 18.57M$ 19.24M$ 15.34M$ 13.72M
Gross Profit$ 4.40M$ 7.65M$ 8.66M$ 6.86M$ 6.74M
Operating Income$ -5.75M$ -2.30M$ -2.20M$ -1.38M$ -954.00K
EBITDA$ -2.50M$ 349.99K$ 2.72M$ 1.65M$ 1.43M
Net Income$ -5.77M$ -2.49M$ -78.00K$ -1.02M$ -1.30M
Balance Sheet
Cash & Short-Term Investments$ 978.74K$ 5.79M$ 10.19M$ 7.95M$ 8.77M
Total Assets$ 43.81M$ 44.86M$ 44.47M$ 40.35M$ 38.69M
Total Debt$ 16.69M$ 12.48M$ 10.27M$ 10.73M$ 8.42M
Net Debt$ 15.71M$ 6.69M$ 89.03K$ 2.79M$ -352.53K
Total Liabilities$ 18.82M$ 14.48M$ 11.89M$ 12.08M$ 9.70M
Stockholders' Equity$ 24.99M$ 30.38M$ 32.58M$ 28.27M$ 28.99M
Cash Flow
Free Cash Flow$ -6.57M$ -5.52M$ -1.65M$ -2.76M$ -1.16M
Operating Cash Flow$ -4.67M$ -1.54M$ 954.17K$ 1.32M$ 233.51K
Investing Cash Flow$ -1.89M$ -3.96M$ -1.60M$ -2.57M$ -3.40M
Financing Cash Flow$ 1.75M$ 1.11M$ 3.88M$ 1.91M$ 6.94M
Currency in USD

Immucell Earnings and Revenue History

Immucell Debt to Assets

Immucell Cash Flow

Immucell Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis